DexaMedica Meropenem Dosage & Drug Information

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Concise Prescribing Info

Contents

Meropenem

Indications/Uses

Pneumonia & nosocomial pneumonia, UTI, intra-abdominal infections, gynaecological infections eg, endometritis & pelvic inflammatory disease, bacterial meningitis, septicaemia in adult & childn. Empiric treatment for presumed infections w/ febrile neutropenia, used as monotherapy or in combination w/ antivirals or antifungals.

Click to view DexaMedica Meropenem detailed prescribing information

Dosage/Direction for Use

Adult Pneumonia, UTI, gynaecological infections eg, endometritis 500 mg IV every 8 hr. Hospital acquired pneumonia, peritonitis, presumed infections in febrile neutropenic patient, septicaemia 1 g IV every 8 hr. Meningitis 2 g every 8 hr. Pseudomonas aeruginosa nosocomial infections Adult & adolescent 2 g tds. Childn Infections >50 kg Adult dose, >3 mth-12 yr 10-20 mg/kg every 8 hr. Meningitis 40 mg/kg every 8 hr. Febrile episodes in neutropenic patient 20 mg/kg every 8 hr. Pseudomonas aeruginosa nosocomial infections 40 mg/kg tds.

Click to view DexaMedica Meropenem detailed prescribing information

Overdosage

View DexaMedica Meropenem overdosage for action to be taken in the event of an overdose.

Contraindications

Hypersensitivity.

Click to view DexaMedica Meropenem detailed prescribing information

Special Precautions

Hypersensitivity reactions to β-lactam antibiotics, overgrowth of nonsusceptible organisms, methicillin-resistant staphylococci infections, history of GI complaints, pseudomembranous colitis, CNS disorders, bacterial meningitis, compromised renal function, hepatic disease. Co-administration w/ potentially nephrotoxic drugs. Pregnancy, not to be used in lactation. Childn w/ altered hepatic or renal function. Not recommended in infant <3 mth.

Click to view DexaMedica Meropenem detailed prescribing information

Use In Pregnancy & Lactation

Click to view DexaMedica Meropenem detailed prescribing information

Adverse Reactions

Inj site inflammation, thrombophlebitis, pain; rash, pruritus, urticaria; abdominal pain, nausea, vomiting, diarrhea, pseudomembranous colitis; thrombocythemia, eosinophilia, thrombocytopenia, leucopenia, neutropenia, haemolytic anemia, bleeding; increased bilirubin, transaminases, alkaline phosphatase, lactic dehydrogenase; headache, paresthesia, convulsions; oral & vag candidiasis.

Click to view DexaMedica Meropenem detailed prescribing information

Drug Interactions

Increased plasma conc by probenecid. Reduced valproic acid levels & anticonvulsant effect. Decreased immunological response to the typhoid vaccine.

Click to view DexaMedica Meropenem detailed prescribing information

Caution For Usage

For caution against possible variation of physical aspect of medicine... Click to view DexaMedica Meropenem detailed prescribing information

Storage

View DexaMedica Meropenem storage conditions for details to ensure optimal shelf-life.

Description

View DexaMedica Meropenem description for details of the chemical structure and excipients (inactive components).

Action

View DexaMedica Meropenem mechanism of action for pharmacodynamics and pharmacokinetics details.

MIMS Class

Other Beta-Lactams

ATC Classification

J01DH02 - meropenem ; Belongs to the class of carbapenems. Used in the systemic treatment of infections.

Regulatory Classification

Presentation/Packing

Form

DexaMedica Meropenem powd for inj 0.5 g

Packing/Price

1's

Form

DexaMedica Meropenem powd for inj 1 g

Packing/Price

1's

DexaMedica Meropenem

meropenem

Manufacturer:

Dexa Medica

Distributor:

Averroes Pharma